AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on May 15, 2008
doi: 10.3174/ajnr.A1111

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1111v1
29/7/1376    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Bisdas, S.
Right arrow Articles by Rumboldt, Z.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bisdas, S.
Right arrow Articles by Rumboldt, Z.

HEAD & NECK

Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging

S. Bisdasa,b, K. Spicera and Z. Rumboldta

a Department of Radiology, Medical University of South Carolina, Charleston, SC
b Department of Radiology, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany

Please address correspondence to Zoran Rumboldt, MD, Department of Radiology, Medical University of South Carolina, 169 Ashley Ave, Charleston, SC 29425; e-mail: rumbolz{at}musc.edu

BACKGROUND AND PURPOSE: Previous (separately performed) perfusion CT (PCT) and PET studies have been inconclusive regarding the correlation of functional tumor characteristics. The purpose of this study was to perform dual assessment of head and neck squamous cell carcinomas (SCCAs) to examine the relationship between perfusion measurements derived from PCT and glucose standardized uptake values (SUV).

MATERIALS AND METHODS: We prospectively evaluated 15 primary and recurrent SCCAs using combined positron-emission tomography (PET) and CT of the head and neck. SUVmean, SUVmax, blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability (PS) values were calculated with use of manually drawn regions of interest (ROIs) over the lesions and the healthy muscle tissue. Parametric comparison test, correlation coefficients, and regression analysis were performed.

RESULTS: The mean (± SD) SUVmean, SUVmax, BF, BV, MTT, and PS values in the tumor tissue were 6.26 (± 1.48), 15.25 (± 3.81), 91.50 (± 24.69), 5.08 (± 1.17), 7.51 (± 2.24), and 23.08 (± 8.77), respectively. All PET/CT and PCT parameters of muscle versus tumor tissue were statistically different (.0001 < P < .001). There were significant correlations between BF and SUVmax as well as SUVmean (r = 0.57; P = .02 and r = 0.63; P = .011, respectively) in the tumors. Significant correlation was also found between PS and SUVmean (r = 0.53; P = .04) in the tumors. Regression analysis showed: SUVmax = 0.09 x BF + 7.2 (R2 = 0.33; P = .02), SUVmean = 0.05 x BF + 2.22 (R2 = 0.45; P = .011), and SUVmean = 0.05 x PS + 5.36 (R2 = 0.35; P = .04). The tumor to nontumor (muscle) SUVmean and SUVmax ratio was 9.45 (± 3.55) and 17.58 (± 4.32), respectively. BF-ratio SUVmean and BF-ratio SUVmax showed significant correlations (r = 0.64; P = .01 and r = 0.53; P = .04, respectively). Regression analysis showed ratio SUVmean = 0.14 x BF-3.48 (R2 = 0.42; P = .01) and ratio SUVmax = 0.14 x BF + 4.51 (R2 = 0.29; P = .04).

CONCLUSION: Tissue perfusion-metabolic coupling is evident in head and neck SCCAs and may provide additional diagnostic information in patients undergoing PET/CT studies.